832 Results

People

  1. Pfister
    Pfister
  2. Lee
    Lee
  3. Sherman
    Sherman
  4. Riaz
    Riaz
  5. Dunn
    Dunn
  6. Wong
    Wong
  7. Ho
    Ho
  8. McBride
    McBride
  9. Shah
    Shah
  10. Tsai
    Tsai

Groups

  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)
  7. Center for Pancreatic Cancer Research (173)
  8. Epidemiology and Biostatistics (162)
  9. Weinberg Fellows (161)
  10. Department of Pathology and Laboratory Medicine (155)
  1. "Head and Neck Service"
Formats
  1. Journal Article (407)
  2. Meeting Abstract (360)
  3. Book Section (20)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (3)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Head and Neck Service (832)
  2. Solid Tumor Oncology Division (832)
  3. Department of Medicine (826)
  4. Surgery (358)
  5. Radiation Oncology, Department of (310)
  6. Survivorship Research (310)

More Groups

People
  1. David Pfister (389)
  2. Eric Sherman (339)
  3. Nancy Lee (266)
  4. Alan Ho (238)
  5. Nadeem Riaz (159)
  6. Lara Dunn (141)

More People

Years
  1. 2025 (12)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (66)

More Years

Publications
  1. Journal of Clinical Oncology (205)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (28)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (219)
  2. Elsevier Inc. (176)
  3. Wiley Blackwell (55)
  4. Oxford University Press (53)
  5. American Association for Cancer Research (46)
  6. Harborside Press (28)

More Publishers

Results (832)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • LIBRETTO-531: Selpercatinib in patients with treatment (Tx)-naive RET-mutant medullary thyroid cancer (MTC)
    Meeting Abstract

    Hernando, J.; Tarasova, V.; Hu, M. I.; Sherman, E. J.; Brose, M. S.; Robinson, B.; Tahara, M.; Wirth, L. J.; Sashegyi, A.; Soldatenkova, V.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab salvage add-on therapy in patients with radioiodine-refractory (RAIR), progressive differentiated thyroid cancer (DTC) progressing on lenvatinib: Results of a multicenter phase II International Thyroid Oncology Group Trial
    Meeting Abstract

    Haugen, B.; French, J. D.; Worden, F.; Konda, B.; Sherman, E. J.; Dadu, R.; Gianoukakis, A. G.; McCue, S.; Foster, N.; Bowles, D. W.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912
    Meeting Abstract

    Sherman, E. J.; Harris, J.; Bible, K. C.; Xia, P.; Ghossein, R. A.; Chung, C. H.; Riaz, N.; Gunn, B.; Foote, R. L.; Yom, S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • ACCURACY a phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut)
    Meeting Abstract

    Ferrarotto, R.; Wirth, L. J.; Muzaffar, J.; Rodriguez, C. P.; Xia, B.; Perez, C. A.; Bowles, D. W.; Winquist, E.; Hotte, S. J.; Metcalf, R.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • SPEARHEAD-2 trial design: A phase II pilot trial of ADP-A2M4 in combination with pembrolizumab in patients with recurrent or metastatic head and neck cancer
    Meeting Abstract

    Cohen, E. E.; Dunn, L.; Neupane, P.; Gibson, M.; Leidner, R.; Savvides, P.; Hyland, N.; Trivedi, T.; Dudley, M.; Biswas, S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Phase I first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumours
    Meeting Abstract

    Powderly, J.; Shimizu, T.; Lorusso, P.; Razak, A.; Miller, K. D.; Balar, A. V.; Bruix, J.; Michel, L. S.; Blaney, M.; Guan, X.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer
    Meeting Abstract

    Gouda, M. A.; Sherman, E. J.; Gilcrease, G. W.; Vaishampayan, U. N.; Parikh, A.; Feun, L.; Kummar, S.; Huang, H.; Zhang, C.; Severson, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Dissecting anaplastic thyroid carcinoma: A comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases
    Journal Article

    Xu, B.; Fuchs, T.; Dogan, S.; Landa, I.; Katabi, N.; Fagin, J. A.; Tuttle, R. M.; Sherman, E.; Gill, A. J.; Ghossein, R.
    Thyroid (2020)

    Fulltext@MSK | Save
  • The importance of locoregional therapy in metastatic nasopharyngeal cancer
    Editorial

    Riaz, N.; Sherman, E.; Lee, N.
    JAMA Oncology (2020)

    Fulltext@MSK | Save